Indiana Gov. Mike Braun announced a $1 billion investment in the state’s agricultural and life sciences industry.
The goal with the investment is to create 100,000 high-wage jobs over 10 years and make Indiana a hub for life sciences innovation on a national and global scale.
“This investment will make Indiana the re-shoring and expansion epicenter and premier destination for human therapeutics, animal health, agritech, biotechnology, and environmental innovation,” Governor Braun said on Tuesday.
Gov. Braun said as part of this $1 billion state commitment, funds will be tied to measurable outcomes to ensure accountability and long-term return on investment.
“The work around plant, human, and animal health in Indiana supports hundreds of thousands of Hoosier jobs and generates billions in annual GDP statewide,” said Braun.
The initiative ties in with Governor Braun’s Executive Order 25-45 that directs Indiana’s regions to submit formal growth plans tied to employment, per capita income, and educational attainment.
The investment will involve key companies like Eli Lilly and Company, Elanco Animal Health, and Corteva Agriscience. Also involved are other innovators including Labcorp, Novartis, and Roche, and research institutions from Indiana University and Purdue University.
On Tuesday, Gov. Braun also designated the Central Indiana Regional Development Authority (CIRDA) as the first regional steward to coordinate alignment and execution of the initiative.
Fishers Mayor Scott Fadness serves as the chair of the CIRDA. He said the regional leadership and convergence behind this initiative is what will make it successful.
“Our job now is alignment by bringing industry, universities, and local communities together under a unified strategy that accelerates growth,” said Mayor Fadness. “CIRDA is ready to serve as the first steward of this effort, and we look forward to partnering with regions across the state as they step forward.”
